jain.com

Over-allotment option exercise and capital raise closure

Company: TeraWulf

Subject kind
financing
Statement date
2023-02-28
Current status
stated

The claim, verbatim

Underwriters exercised their over-allotment option and purchased 1,000,000 additional shares at $0.68 per share, resulting in approximately $26.63 million in total net proceeds to the company.

Source (primary)

TeraWulf 8-K filed 2023-03-01 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “On February 28, 2023, the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 1,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $0.64 million, or approximately $26.63 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”

How we checked this

Attempted on September 21, 2026. We could not read enough of the cited source to check this claim.

The verification run did not return a result for this claim (claude -p exit 1: b'').

What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1083301/000108330123000024/wulf-20230301x8k.htm) in full (3,050 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms TeraWulf 8-K filed 2023-03-01

Quote: “On February 28, 2023, the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 1,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $0.64 million, or approximately $26.63 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”

View cached copy (2026-09-13)Live source ↗